Osterweis Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Hold |
0
| – | – | – | 51 |
|
|
2025
Q4 | – | Hold |
0
| – | – | – | 55 |
|
|
2025
Q3 | – | Hold |
0
| – | – | – | 53 |
|
|
2025
Q2 | – | Hold |
0
| – | – | – | 50 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 63 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 78 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 66 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 63 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 62 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 55 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 54 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 58 |
|
|
2023
Q1 | – | Sell |
-60,823
| Closed | -$5.31M | – | 73 |
|
|
2022
Q4 | $5.52M | Buy |
60,823
+902
| +2% | +$76K | 0.4% | 69 |
|
|
2022
Q3 | $4.55M | Sell |
59,921
-455
| -0.8% | -$37.7K | 0.34% | 76 |
|
|
2022
Q2 | $5.1M | Buy |
60,376
+22
| +0% | +$1.93K | 0.38% | 71 |
|
|
2022
Q1 | $5.3M | Sell |
60,354
-222
| -0.4% | -$19.2K | 0.29% | 87 |
|
|
2021
Q4 | $5.3M | Sell |
60,576
-18,491
| -23% | -$1.54M | 0.27% | 89 |
|
|
2021
Q3 | $6.47M | Sell |
79,067
-194,998
| -71% | -$17.5M | 0.35% | 81 |
|
|
2021
Q2 | $25M | Sell |
274,065
-9,930
| -3% | -$884K | 1.29% | 28 |
|
|
2021
Q1 | $24.3M | Buy |
283,995
+25
| +0% | +$2.24K | 1.32% | 30 |
|
|
2020
Q4 | $26.8M | Buy |
283,970
+49,365
| +21% | +$4.31M | 1.6% | 26 |
|
|
2020
Q3 | $20.4M | Sell |
234,605
-38,794
| -14% | -$3.36M | 1.38% | 33 |
|
|
2020
Q2 | $23.9M | Sell |
273,399
-17,325
| -6% | -$1.5M | 1.73% | 19 |
|
|
2020
Q1 | $24M | Sell |
290,724
-10,915
| -4% | -$974K | 1.95% | 17 |
|
|
2019
Q4 | $28.6M | Sell |
301,639
-1,866
| -0.6% | -$167K | 1.98% | 15 |
|
|
2019
Q3 | $26.4M | Sell |
303,505
-2,740
| -0.9% | -$246K | 1.92% | 15 |
|
|
2019
Q2 | $28M | Sell |
306,245
-34,105
| -10% | -$2.89M | 1.98% | 15 |
|
|
2019
Q1 | $29.3M | Sell |
340,350
-74,883
| -18% | -$6.01M | 1.83% | 17 |
|
|
2018
Q4 | $31.9M | Sell |
415,233
-27,192
| -6% | -$2.12M | 2.46% | 10 |
|
|
2018
Q3 | $34.2M | Sell |
442,425
-116,443
| -21% | -$8.61M | 2.18% | 10 |
|
|
2018
Q2 | $37.8M | Sell |
558,868
-17,700
| -3% | -$1.22M | 2.45% | 10 |
|
|
2018
Q1 | $41.8M | Sell |
576,568
-29,652
| -5% | -$2.26M | 2.97% | 5 |
|
|
2017
Q4 | $45.6M | Buy |
606,220
+11,986
| +2% | +$904K | 3.24% | 2 |
|
|
2017
Q3 | $45.7M | Sell |
594,234
-17,284
| -3% | -$1.31M | 3.43% | 2 |
|
|
2017
Q2 | $45.7M | Buy |
611,518
+5,452
| +0.9% | +$386K | 3.48% | 4 |
|
|
2017
Q1 | $40.3M | Buy |
606,066
+201,161
| +50% | +$13.4M | 3.16% | 8 |
|
|
2016
Q4 | $26.4M | Sell |
404,905
-157,228
| -28% | -$10.2M | 1.9% | 27 |
|
|
2016
Q3 | $39.8M | Sell |
562,133
-27,566
| -5% | -$2.01M | 2.39% | 18 |
|
|
2016
Q2 | $43.6M | Sell |
589,699
-130,851
| -18% | -$9.04M | 2.78% | 16 |
|
|
2016
Q1 | $46.8M | Buy |
720,550
+275,639
| +62% | +$18.8M | 2.72% | 17 |
|
|
2015
Q4 | $34.3M | Sell |
444,911
-281,678
| -39% | -$22.4M | 3.16% | 18 |
|
|
2015
Q3 | $59.8M | Sell |
726,589
-3,872
| -0.5% | -$345K | 2.71% | 20 |
|
|
2015
Q2 | $64.4M | Sell |
730,461
-35,260
| -5% | -$3.23M | 2.24% | 23 |
|
|
2015
Q1 | $67.7M | Sell |
765,721
-7,583
| -1% | -$673K | 2.16% | 26 |
|
|
2014
Q4 | $64.2M | Sell |
773,304
-35,304
| -4% | -$2.93M | 2.1% | 28 |
|
|
2014
Q3 | $68.2M | Buy |
808,608
+21,762
| +3% | +$1.76M | 2.1% | 28 |
|
|
2014
Q2 | $63.8M | Buy |
786,846
+12,377
| +2% | +$974K | 1.83% | 34 |
|
|
2014
Q1 | $59M | Buy |
774,469
+9,062
| +1% | +$660K | 1.81% | 32 |
|
|
2013
Q4 | $55.1M | Buy |
765,407
+11,722
| +2% | +$815K | 1.71% | 32 |
|
|
2013
Q3 | $52.4M | Buy |
753,685
+11,288
| +2% | +$747K | 1.69% | 32 |
|
|
2013
Q2 | $47M | Buy |
+742,397
| New | +$48.3M | 1.76% | 30 |
|
Other funds holding NVS
Osterweis Capital Management's NVS Position: Q1 2026 in Review
Osterweis Capital Management held its Novartis (NVS) position steady in Q1 2026 at 0 shares worth $12.8M. The position accounts for 0.66% of the portfolio, ranked #51.
Osterweis Capital Management first reported a position in NVS in Q2 2013 and has held it in 39 quarters since. The position peaked at $68.2M in Q3 2014. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Osterweis Capital Management held 0 shares of Novartis worth $12.8M as of Q1 2026.
- Osterweis Capital Management left its Novartis share count unchanged in Q1 2026.
- Novartis made up 0.66% of Osterweis Capital Management's portfolio in Q1 2026, its #51 holding.
- Osterweis Capital Management first reported a position in Novartis in Q2 2013 and has held it in 39 quarters since.
- Osterweis Capital Management's Novartis position peaked at $68.2M in Q3 2014.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Osterweis Capital Management's 13F filing for Q1 2026, filed 15 May 2026.